We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · December 31, 2020

12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation

JACC: Cardiovascular interventions

 

Additional Info

Disclosure statements are available on the authors' profiles:

JACC: Cardiovascular interventions
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation
JACC Cardiovasc Interv 2020 Dec 28;13(24)2922-2933, M Azizi, J Daemen, MD Lobo, F Mahfoud, ASP Sharp, RE Schmieder, Y Wang, M Saxena, P Lurz, J Sayer, MJ Bloch, J Basile, MA Weber, LC Rump, T Levy, M Sapoval, K Sanghvi, F Rader, NDL Fisher, P Gosse, J Abraham, L Claude, NC Barman, CK McClure, Y Liu, AJ Kirtane

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading